Xcel Energy Inc stock (US98389B1008): shares steady as investors digest New Mexico expansion plans a
Xcel Energy Inc. (XEL) shares remained steady on May 29, 2026, as investors evaluated the regulated utility's extensive multi-year investment program in New Mexico and its current trading range. The company's stock was trading around $79, within sight of its 52-week high, while the market assessed its regulated growth strategy against a cautious interest-rate environment. Xcel Energy's long-term plan includes a $9.38 billion infrastructure build-out in New Mexico by 2039, alongside projections of significant revenue and earnings growth by 2029, making investor focus center on the execution of these capital-intensive projects and upcoming financial reports.
DTE Energy Co. stock (US2333311072): $1.6 billion Michigan battery storage plan highlights grid and data center push
DTE Energy Co. is investing approximately $1.6 billion in battery storage projects in Michigan, in partnership with LG Energy Solution Vertech. This initiative aims to enhance grid reliability and address the increasing power demands from data centers, with the stock's performance influenced by capital spending and regulatory decisions. The utility's shares trade on the NYSE, with additional access for European investors via Tradegate.
Garmin Ltd. stock (CH0114405324): Nasdaq shares edge higher after recent quarterly update
Garmin Ltd.'s shares on Nasdaq saw a modest increase following the company's latest quarterly earnings and guidance. The Switzerland-registered GPS and wearables specialist, listed under GRMN, remains a key player in the US consumer electronics and navigation technology space, with its stock influenced by both company-specific news and broader market trends. Investors are closely monitoring revenue trends, profitability metrics, and segment performance across its diverse product categories like fitness wearables, automotive navigation, and marine electronics.
Citi Revises DOW Outlook amid Emerging Demand Destruction Concerns
Citi has revised its outlook for Dow Inc. (NYSE: DOW), lowering its price target from $48 to $41 due to normalizing chemical prices and burgeoning demand destruction, while maintaining a Buy rating. This contrasts with an earlier upgrade by Argus to Buy, which cited potential supply pressures from the Strait of Hormuz closure. Dow Inc. operates through segments including Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.
Piper Sandler Raises Aflac (AFL) Price Target, Favors Insurance Carriers over Brokers
Piper Sandler upgraded Aflac (AFL) by raising its price target to $130 from $125 and maintaining an Overweight rating. The firm favors insurance carriers over brokers, citing stronger underwriting performance from carriers and weaker organic growth from brokers in their first-quarter results. Aflac, which provides supplemental health and life insurance, is also noted as one of the best long-term dividend stocks according to billionaires.
ExxonMobil, ConocoPhillips negotiate possible Venezuela comeback
ExxonMobil and ConocoPhillips are in active negotiations with the Venezuelan government regarding re-entry into the country's oil sector after a two-decade absence. The companies are seeking durable contract terms and a resolution for billions of dollars owed, while Venezuela is keen to attract foreign investment to stabilize its economy and rebuild its oil infrastructure. Both sides face challenges, including ensuring political stability for long-term investment and structuring deals that address past nationalizations and current oil laws.
Evercore ISI Upgrades Hershey (HSY) on Confidence in Second-Half 2026 Plans
Evercore ISI upgraded The Hershey Company (HSY) to Outperform from In Line, reiterating a $255 price target, despite a "disappointing" Easter season. This upgrade is based on constructive views on the confectionery category and Hershey's plans for the second half of 2026. Earlier, DA Davidson lowered its price recommendation to $208, maintaining a Neutral rating due to intense competition and consumer pressure, though noting HSY's valuation was more attractive.
Incyte (INCY) Reports Positive Phase 3 Trial Results for Tafasit
Incyte (INCY) announced positive results from its Phase 3 frontMIND trial for tafasitamab combined with lenalidomide, showing a 25% reduction in disease progression or mortality in adults with untreated DLBCL. The company, with a market cap of $19.33 billion and a GF Score⢠of 89/100, demonstrates strong financial health and growth potential. While insider selling has occurred, the trial results and attractive P/E ratio of 13.66 suggest a positive outlook for future growth in oncology.
Analyst Sees GME-Style Gamma Squeeze In Hyperliquid's PURR Within 60 Days
An analyst from Capital Flows predicts a GameStop-style gamma squeeze for Hyperliquid Strategies Inc.'s PURR stock within the next 60 trading days, citing its small float, $1.4 billion market cap, and recent high trading volume. The thesis is supported by PURR's upcoming inclusion in the Russell 2000 and 3000 indexes on June 26, and a potential "everything rally" in the current credit cycle. The analyst, whose largest personal position is PURR, also notes rising implied volatility and high call demand for the stock, despite the highly speculative nature of such low-float squeeze setups.
Pumpkin Spice Latte: What Starbucks Fans Should Know
This article details the Starbucks Pumpkin Spice Latte (PSL), describing it as a seasonal espresso beverage made with milk, pumpkin flavor, and warm spices, available each fall for a limited time in the United States and select international markets. It highlights the PSL's cultural significance as a signifier of the autumn season for US consumers and its impact on broader seasonal product categories. The article also provides details on the drink's customizable nature and forms (hot, iced, or blended).




